Period Ending | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 | Jun 29, 2011 |
---|
Total Revenue
|
816,488
|
462,363
|
1,140,835
|
1,117,976
| Cost of Revenue | 200,098 | 175,209 | 209,677 | 200,776 | |
Gross Profit
|
616,390
|
287,154
|
931,158
|
917,200
| |
|
Operating Expenses |
|
Research Development |
-
|
-
| (213,345) | 213,345 |
|
Selling General and Administrative | 564,561 | 420,614 | 842,069 | 393,790 |
|
Non Recurring | (276) | 12,525 | 5,122 | 850 |
|
Others | 3,422 | (1,031) | 7,959 | 9,163 |
|
|
|
Total Operating Expenses |
-
|
-
| 641,805 | 617,148 | | |
Operating Income or Loss
|
48,683
|
(144,954)
|
289,353
|
300,052
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (464) | 1,502 | 13,881 | 1,645 |
|
Earnings Before Interest And Taxes | 48,219 | (143,452) | 303,234 | 301,697 |
|
Interest Expense | 21,392 | (3,814) | 32,049 | 39,961 |
|
Income Before Tax | 26,827 | (139,638) | 271,185 | 261,736 |
|
Income Tax Expense | 5,240 | (62,474) | 60,779 | 74,540 |
|
Minority Interest | (979) | (770) | (872) | (497) |
|
|
|
Net Income From Continuing Ops | 21,587 | (75,625) | 209,534 | 186,529 | |
|
Non-recurring Events |
|
Discontinued Operations | (23,889) | 148,262 |
-
| (46,306) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
(3,281)
|
70,328
|
209,534
|
140,393
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
(3,281)
|
70,328
|
209,534
|
140,393
|
|